(Date:11/21/2009)...isions of Legislation, Continues Push for Progress...ov. 21 With the U.S. ...rdable Health Care for America Act (H.R. 3962), an...forward, Congress has taken decisive steps to fix ...RP hosted an educational forum to discuss the prov...
(Date:11/21/2009)...l apparel company launches men,s lab coats at Medi...Clemente, Calif. (PRWEB) November 21, 2009 -- Mede...today announced the launch of its men,s lab coats,...ternational trade fair for the medical industry he...s men,s collection with three varying lab coat sty...
(Date:11/21/2009)...Group merges their practice with that of E. Steven... (PRWEB) November 21, 2009 -- The New Hav...ibson, Dr. Dean Cloutier, Dr. John Plachtyna and D...practice with that of esteemed colleague Dr. E. St...ed to retire from dentistry in order to concentrat...
(Date:11/20/2009)...ire-FirstCall/ - NUCRYST Pharmaceuticals Corp. ann...s will be held on Monday, December 21, 2009. The p...wo special resolutions. The first special resoluti...substantially all of the assets of NUCRYST, substa...chase agreement dated November 10, 2009 among the ...
(Date:11/20/2009)...re/ -- Following a recall by Unilever The Stop &am...d,s Country Crock ® Side Dishes DELUXE Chedda...ide Dishes DELUXE Four Cheese Pasta due to an unde... dates and UPCs are affected: ,, Shedd,s Count...i Rice 21 oz, UPC 027400218316, Best By NOV 29 09 ...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2... facility on Sand Canyon Avenue , ...- Hoag Memorial Hospital Presbyterian has reached ...tate Investment Trust headquartered in Long Beach,...Tenet Healthcare Corporation (NYSE: THC) as Irvine...
... today announced a revised date to report its 2008.... ev3 will now report its 2008 second quarter,and ... 2008, after regular,market trading hours., The c...w its second quarter operating results and future,...
... Experience it at http://SutterHealth.org/an... an e-patient?,Studies show that 80 percent of Ame...ion. Thanks to Web 2.0, e-patients now have even m...alreport ,and you,ll see one of the ways Sutter He...
...ent-resistant, study shows , , THURSDAY, J...e evidence that a new AIDS drug brings significant...ents. , The drug, known as raltegravir (Isentress)...y 24 issue of the New England Journal of Medicine...
...lth and,safety services company, today announced t...les to Living Abroad.com and its multi-national em...-filled online guides to trusted,medical care in h...e assigned abroad on topics such as health service...
...Frank,Ervolino, ND, investigated a product that cl...isks associated with stimulants. He reports that,A...tural product from Zurich,Pharmaceuticals, makes n...DC estimates that greater than 30% of adults are o...
Other Medicine News:Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 3Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 4Health News:Drug Holds Promise Against AIDS 2Health News:HTH Worldwide to Provide International Health Guide to Living Abroad.com 2Health News:New Natural Product from Zurich Pharmaceuticals Downs Appetite 2...e SNS-595 to Next Stage of Phase 2 Trial Achieved,...OR RELEASE AT 3:30 P.M. EDT, TODAY/ -- Sunesis Pha...age biopharmaceutical company developing novel,ant...liminary results from,the first stage of the compa...oduct candidate, SNS-595, in platinum-resistant ov...
...WASHINGTON, Oct. 23 Boston,Scientific Corporation...,results from its CABERNET and BEACH carotid arter...the effectiveness of stenting with embolic,protect...ectomy (CEA), the,surgical treatment for carotid a...esults were presented by L. Nelson Hopkins, M.D., ...
Other Medicine Technology:Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 2Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 3Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 4Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 5Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 2Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 3Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 4Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 5Bledsoe Extender Knee Brace
Bledsoe Post-Op Knee Brace
Bledsoe Basic Knee Brace
Extensor™ Patellar Knee Support with Lateral Strap
Medicine Products: